These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 18386298)
1. Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores. Kuroda K; Horiguchi A; Asano T; Asano T; Hayakawa M Prostate; 2008 Jul; 68(10):1057-63. PubMed ID: 18386298 [TBL] [Abstract][Full Text] [Related]
2. Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer. Kuroda K; Horiguchi A; Asano T; Tasaki S; Yoshii H; Sato A; Asakuma J; Ito K; Seguchi K; Sumitomo M; Asano T Urol Int; 2012; 88(1):18-24. PubMed ID: 22222198 [TBL] [Abstract][Full Text] [Related]
3. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Miyake H; Sakai I; Harada K; Eto H; Hara I Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782 [TBL] [Abstract][Full Text] [Related]
4. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964 [TBL] [Abstract][Full Text] [Related]
5. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973 [TBL] [Abstract][Full Text] [Related]
7. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy. Sankin A; Tareen B; Lepor H Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170 [TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. Shariat SF; Khoddami SM; Saboorian H; Koeneman KS; Sagalowsky AI; Cadeddu JA; McConnell JD; Holmes MN; Roehrborn CG J Urol; 2004 Mar; 171(3):1122-7. PubMed ID: 14767284 [TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea. Kim HS; Sung W; Lee S; Chang SG; Park YK Pathol Res Pract; 2009; 205(4):249-54. PubMed ID: 19058917 [TBL] [Abstract][Full Text] [Related]
11. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653 [TBL] [Abstract][Full Text] [Related]
12. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy. Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452 [TBL] [Abstract][Full Text] [Related]
13. Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. Nishimoto K; Nakashima J; Hashiguchi A; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M; Murai M Int J Urol; 2008 Jun; 15(6):520-3. PubMed ID: 18422574 [TBL] [Abstract][Full Text] [Related]
14. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Briganti A; Karakiewicz PI; Chun FK; Gallina A; Salonia A; Zanni G; Valiquette L; Graefen M; Huland H; Rigatti P; Montorsi F Eur Urol; 2007 Jun; 51(6):1573-81. PubMed ID: 17293026 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer volume at biopsy predicts clinically significant upgrading. Dong F; Jones JS; Stephenson AJ; Magi-Galluzzi C; Reuther AM; Klein EA J Urol; 2008 Mar; 179(3):896-900; discussion 900. PubMed ID: 18207180 [TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel density and lymph node metastasis in prostate cancer. Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136 [TBL] [Abstract][Full Text] [Related]
17. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens. Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059 [TBL] [Abstract][Full Text] [Related]
18. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695 [TBL] [Abstract][Full Text] [Related]
19. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877 [TBL] [Abstract][Full Text] [Related]